Patients undergoing abdominal laparoscopy or laparotomy
Conditions
Interventions
Trade Name: Naropin 0,75% (R): Ropivacaine 0,75%: (Astra-Zeneca)
Iomeron 300: 61,24% w/v of iomeprol equivalent to 30% iodine or 300mg iodine/ml (Bracco UK Limited)
Pharmaceutical Form:
Sponsors
Department of Anesthesia Reanimation of University of Liege
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adults patients undergoing abdominal surgery Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 50 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 10
Exclusion criteria
Exclusion criteria: Allergy to local anesthetics, or contrast media coagulation disorder and renal dysfunction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To determine the mechanism of action of the quadrates lumborum block for pain relief after abdominal surgery;Secondary Objective: To examine different approaches for the quadrates lumborum block and determine the best one;Primary end point(s): Determine the mechanism of action of the different approaches;Timepoint(s) of evaluation of this end point: Two hours after completion of the surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): No secondary end points;Timepoint(s) of evaluation of this end point: 3 Hours postoperatively | — |
Countries
Belgium
Outcome results
None listed